Here are six takeaways:
1. By 2020, the market is expected to hit $818 million, increasing at a compound annual growing rate of 8.9 percent.
2. The market was valued at $447 million last year.
3. Factors spurring market growth include an increasing aging population, higher adoption of minimally invasive surgeries, more research and development activity in life sciences and an overall growth in healthcare infrastructure.
4. The escalated cost of equipment in developing regions may hinder market growth.
5. Asia-Pacific is expected to have the fastest growth through 2022 due to a growing population, more healthcare infrastructure initiatives and favorable reimbursement.
6. Key players include ACCU-SCOPE, Alltion, Haag-Streit U.S., Alcon Laboratories, Olympus, Leica Microsystem, ARRI , Carl Zeiss, Global Surgical, Topcon Medical Systems and TAKAGI SEIKO.
More device news:
FDA’s Center for Devices and Radiological Health zones in on health IT in 2017 — 5 insights
Global orthopedic devices market to hit $41.2B by 2019: 8 highlights
Nasseo awarded NSF grant for spinal implant research: 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
